Showing results (801-810 of 2,733) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|January 19, 2022
Pharmacogenetic differentiation across Latin AmericaGuilherme Suarez-Kurtz, Gilderlanio Santana de Araújo
Pharmacogenomics|February 16, 2019
Genetics of clozapine-associated neutropenia: recent advances, challenges and future perspectiveSophie E Legge, James Tr Walters
Pharmacogenomics|January 15, 2021
Use of hiPSC to explicate genomic predisposition to anthracycline-induced cardiotoxicityTarek Magdy, Paul W Burridge
Pharmacogenomics|December 15, 2016
Suppression of miR-628-3p and miR-641 is involved in rifampin-mediated CYP3A4 induction in HepaRG cellsLiang Yan, Jingyang Liu, Yunlong Zhao, et al.
Pharmacogenomics|March 31, 2017
Common genetic polymorphisms of adenosine A2A receptor do not influence response to regadenosonMark Berlacher, Ronald Mastouri, Santosh Philips, et al.
Pharmacogenomics|March 31, 2017
Pharmacogenetics in the treatment of pre-eclampsia: current findings, challenges and perspectivesMarcelo R Luizon, Ana Ct Palei, Ricardo C Cavalli, et al.
Pharmacogenomics|March 28, 2017
The role of germline variants in chemotherapy outcome in brain tumors: a systematic review of pharmacogenetic studiesMarije J Klumpers, Marieke Jh Coenen, Corrie Em Gidding, et al.
Pharmacogenomics|November 8, 2021
Frequency and impact of DHODH, ABCG2 and CYP2C19 SNPs on the therapeutic efficacy, tolerability and toxicity of leflunomideYasmine S Makarem, Mohammad Salem Hareedy, Manal Hassanien, et al.
Pharmacogenomics|November 24, 2021
The association between HLA-B*15:02 and phenytoin-induced severe cutaneous adverse reactions: a meta-analysisThanh Huong Phung, Khanh Ngoc Cong Duong, Mac Ardy Junio Gloria, et al.
Pharmacogenomics|March 5, 2021
Developing a gene panel for pharmacoresistant epilepsy: a review of epilepsy pharmacogeneticsAstrid J Rodriguez-Acevedo, Louisa G Gordon, Nicola Waddell, et al.
Pageof 274